Skip to main content
PolicySpeak
← All files
MDM

Medical Device Manufacturers Association (MDMA

Industry association · United States · EU Transparency Register 991141248676-03

2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1205 trade and business associations on this site, they rank #821 by legislative files engaged — a count of participation, not a measure of influence.

0.1
declared lobbying FTE
self-declared
€10K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2023
in the register since
Register category
Trade and business associations
Registered as
Medical Device Manufacturers Association (MDMA)
Head office
Washington, DC, United states

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Medical in PolicySpeak: request access →

Work at Medical Device Manufacturers Association (MDMA? so we know who speaks for it.

Follow the file Medical Device Manufacturers Association (MDMA engages with

One email on Tuesdays when a new position is filed on this file, from Medical Device Manufacturers Association (MDMA or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Medical Device Manufacturers Association (MDMA filed 2 positions between 6 Oct 2025 and 21 Feb 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 21 Feb 2026PDFsource

The Medical Device Manufacturers Association -MDMA (a US-based trade association that represents hundreds of innovative medtech companies) supports the EU Commissions efforts to streamline, simplify and reduce the time and cost for bringing safe and effective MDR and IVDR medical innovations to hospitals, doctors and patients across the EU. This is both a critical and noble goal.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025source

Call for Evidence MDR / IVDR: Comments from MDMA (Medical Device Manufacturers Association) based in Washington DC with regulatory advisor in Brussels. MDMA welcomes the opportunity to submit evidence. The new regulatory framework should address the problems with the current system, which especially impact SMEs, as follows: -There should be recognition of the predominance of SME participation in the medtech sector.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Medical Device Manufacturers Association (MDMA’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.